EPISODE · Nov 11, 2020 · 23 MIN
Everything you need to know about Pfizer's COVID-19 vaccine
from Front Burner
This week, as COVID-19 cases continue to climb across the country, there is a glimmer of hope for returning to normal life: a vaccine. Pharmaceutical companies Pfizer and BioNTech say that results from a Phase 3 study of their vaccine candidate look promising and that immunity could last a year. Today, we hear from CBC science and technology reporter Emily Chung on what we know about the Pfizer-BioNTech vaccine that early results suggest is 90 per cent effective in preventing COVID-19.
What this episode covers
This week, as COVID-19 cases continue to climb across the country, there is a glimmer of hope for returning to normal life: a vaccine. Pharmaceutical companies Pfizer and BioNTech say that results from a Phase 3 study of their vaccine candidate look promising and that immunity could last a year. Today, we hear from CBC science and technology reporter Emily Chung on what we know about the Pfizer-BioNTech vaccine that early results suggest is 90 per cent effective in preventing COVID-19.
NOW PLAYING
Everything you need to know about Pfizer's COVID-19 vaccine
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.